Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
2 raisons identifiées
Auteur de référence en rhumatologie
24 articles scientifiques publiés — un praticien à la pointe de la recherche
Délais de RDV courts dans la région
146.3 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
CABINET DU DR RENE LAVOT
54 RUE DU FAUBOURG DES 3 MAISONS, 54000 NANCY
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
The Pediatric infectious disease journal · 2025
Background: In Catalonia, infants <6 months old were eligible to receive nirsevimab, a novel monoclonal antibody against respiratory syncytial virus (RSV). We aimed to analyze nirsevimab’s effectiveness in hospital-related outcomes of the seasonal cohort (born during the RSV epidemic from October to January 2024) and compared them with the catch-up cohort (born from April to September 2023). Methods: Retrospective cohort study of all infants born between October 1, 2023, and January 21, 2024, according to their immunization with nirsevimab (immunized and nonimmunized). We followed individuals until the earliest of an outcome—hospital emergency visits, hospital admission or pediatric intensive care unit (PICU) admission due to RSV-associated or all-causes bronchiolitis—death or the end of the study. We used the Kaplan-Meier estimator and fitted Cox regression models using a calendar time scale to estimate hazard ratios (HRs) and their 95% confidence interval (CI). Sensitivity analysis was performed through matching. Results: Among 15,341 infants, a dose of nirsevimab led to an adjusted HR for hospital admission, PICU admission and emergency visits due to RSV bronchiolitis of 0.26 (95% CI: 0.17–0.39), 0.15 (95% CI: 0.07–0.28) and 0.46 (95% CI: 0.23–0.90), respectively. For all-causes bronchiolitis, the former adjusted HRs were 0.45 (95% CI: 0.31–0.63), 0.23 (95% CI: 0.13–0.41) and 0.49 (95% CI: 0.35–0.68), respectively. Conclusions: Nirsevimab was associated with reductions of 74% and 85% hospitalizations and PICU admissions regarding RSV-associated bronchiolitis, respectively. These percentages are slightly lower than those for the catch-up cohort. This information may help the implementation of RSV-immunization campaigns by public health authorities.
International journal of biological macromolecules · 2025
Phytomedicine : international journal of phytotherapy and phytopharmacology · 2024
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Vector borne and zoonotic diseases (Larchmont, N.Y.) · 2026 · Journal Article
Aguilar C, Oraby T, Torres-Avila M, René SL, et al.
Cureus · 2025 · Journal Article
Raoof A, Rathod J, Banothu G, Kummari S, et al.
Journal of neuromuscular diseases · 2025 · Journal Article
Walter MC, Günther B, Astrid B, Marcus D, et al.
The Journal of steroid biochemistry and molecular biology · 2025 · Journal Article
Sanaye M, Alva M, Wani T, Banerjee A, et al.
International journal of biological macromolecules · 2025 · Journal Article
Rajesh A, Sajeev D, R NK, Rangasamy J, et al.
Rheumatology (Oxford, England) · 2025 · Journal Article
Jha A, R C, Yadav B, Simon B, et al.
Oral and maxillofacial surgery · 2025 · Journal Article
Vladimír M, Vasilis V, Michal B, René F, et al.
Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2025 · Journal Article
Di Salle G, Atallah A, van Dokkum LE, Gascou G, et al.
Bioinformation · 2025 · Journal Article
Ari G, Mohit J, Vilas K, K T, et al.
Phytomedicine : international journal of phytotherapy and phytopharmacology · 2024 · Journal Article
Ren J, Xiang B, Song L, René DJ, et al.
Technical innovations & patient support in radiation oncology · 2024 · Journal Article
Pignier M, Rene L, Carenco J, Dubosc M, et al.
Journal of neurointerventional surgery · 2025 · Journal Article
Cagnazzo F, Atallah A, van Dokkum LEH, Capirossi C, et al.
European journal of pediatrics · 2025 · Journal Article
Coma E, Martínez-Marcos M, Hermosilla E, Mendioroz J, et al.
The Pediatric infectious disease journal · 2025 · Journal Article
Perramon-Malavez A, Hermosilla E, Coma E, Fina F, et al.
Best practice & research. Clinical obstetrics & gynaecology · 2026 · Journal Article
Worrall S, Dasgupta T, Powell S, Devita S, et al.
Cureus · 2026 · Journal Article
R GS, K N
Health economics review · 2025 · Journal Article
Shobha V, Singhai S, Haridas V, V S, et al.
Clinical nutrition ESPEN · 2025 · Journal Article
J N H, G G, Mahadevan S, R I
BMC public health · 2026 · Journal Article
Mora N, Palomar-Cros A, Pérez-Crespo L, Méndez-Boo L, et al.
The Pediatric infectious disease journal · 2025 · Journal Article
Perramon-Malavez A, Hermosilla E, Coma E, Fina F, et al.
Best practice & research. Clinical obstetrics & gynaecology · 2026 · Journal Article
Worrall S, Dasgupta T, Powell S, Devita S, et al.
Clinical nutrition ESPEN · 2025 · Journal Article
J N H, G G, Mahadevan S, R I
Best practice & research. Clinical obstetrics & gynaecology · 2026 · Journal Article
Worrall S, Dasgupta T, Powell S, Devita S, et al.
Spanish journal of psychiatry and mental health · 2025 · Journal Article
Maturana-Quijada P, Chavarría-Elizondo P, Del Cerro I, Martínez-Zalacaín I, et al.
Archives of disease in childhood · 2025 · Letter
Coma E, Martinez-Marcos M, Hermosilla E, Mendioroz J, et al.
The Pediatric infectious disease journal · 2025 · Journal Article
Perramon-Malavez A, Hermosilla E, Coma E, Fina F, et al.
Cureus · 2025 · Case Reports
K R, J P, R R, B V MM, et al.
Cureus · 2026 · Case Reports
R S, Nanda M S, Adalarasan S, Subramanian Y, et al.
Journal of registry management · 2025 · Journal Article
Retell J, Francis S, Rene J, Baade P